• Bài báo tạp chí
  • Nhan đề: Rationale and Design of LAPLACE-2: A Phase 3, Randomized, Double-Blind, Placebo- and Ezetimibe-Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Subjects With Hypercholesterolemia on Background Statin Therapy / Jennifer G. Robinson and others

Nhan đề Rationale and Design of LAPLACE-2: A Phase 3, Randomized, Double-Blind, Placebo- and Ezetimibe-Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Subjects With Hypercholesterolemia on Background Statin Therapy / Jennifer G. Robinson and others
Mô tả vật lý From p.4-12
Tác giả(bs) CN Fialkow, Jonathan
Tác giả(bs) CN Nedergaard, Bettina S.
Tác giả(bs) CN Robinson, Jennifer G.
Tác giả(bs) CN Rogers, William J.
Nguồn trích Clinical cardiology- Số: 4 Tập: 37 Năm: 2014
000 00000nab#a2200000ui#4500
001210132
00221
0049745A37A-6BC0-4C40-A524-12FB3F72E202
005202411051332
008081223s vm| vie
0091 0
039|y20241105133226|zluuyen
245 |aRationale and Design of LAPLACE-2: A Phase 3, Randomized, Double-Blind, Placebo- and Ezetimibe-Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Subjects With Hypercholesterolemia on Background Statin Therapy / |cJennifer G. Robinson and others
300 |aFrom p.4-12
700 |aFialkow, Jonathan
700 |aNedergaard, Bettina S.
700 |aRobinson, Jennifer G.
700 |aRogers, William J.
773 |tClinical cardiology|d2014|v37|i4
890|c1
Không tìm thấy biểu ghi nào
Nhận xét